A quantitative tool for honest stock research
Tessera Research builds tools that rank US-listed stocks by sector-relative valuation. Most stock research either drowns you in tickers without a framework, or wraps a thin opinion in a confident UI. We do neither.
What it does
Every week, the system scores 4,000+ US-listed stocks on 24 fundamental and technical factors — profitability, growth, balance sheet strength, momentum, earnings quality, and more. It then ranks each stock by P/E discount versus its sector median, because a 15× P/E in tech and a 15× P/E in utilities are not comparable on absolute terms.
On top of the screen, you can backtest custom strategies against 10 years of point-in-time historical data — with proper protection against survivorship and look-ahead bias. Results include CAGR, Sharpe ratio, max drawdown, and benchmark comparison.
Why sector-relative
Absolute multiples mislead across sectors. A 15× P/E in software looks expensive next to a 12× P/E in regional banking, but adjusted for growth, capital intensity, and historical multiple compression patterns, the comparison is meaningless. Sector-relative ranking asks the only question that scales: is this stock cheap against the businesses it actually competes with?
We rank every name in our universe against its sector median on P/E, then layer 24 quality factors on top so you don't buy the cheapest junk in the sector. The methodology is fully documented, including its limitations and failure modes.
How we report performance
Every backtest claim on this site sits behind a single page — backtest disclosure — with full assumptions, limitations, and the regime-dependence caveats spelled out. Hero copy, marketing surfaces, and pricing pages do not lead with hypothetical performance numbers, because we believe doing so misleads readers and creates a regulatory posture we'd rather not occupy. If you want the raw numbers, they're on the disclosure page; if you want the philosophy, keep reading.
What it isn't
- It is not investment advice. It is a research tool.
- It does not place trades, hold custody of money, or integrate with any broker. The only execution mode is paper trading (simulated portfolios for tracking how a strategy would have performed).
- Backtested performance is hypothetical and not predictive of future returns. Markets, regimes, and factor effectiveness change.
- It does not cover non-US-listed equities, options, futures, or crypto.
- It does not provide personalized recommendations. Tessera Research is not a registered investment adviser.
Philosophy
Sector-relative analysis. Multi-factor scoring. Point-in-time data. Honest reporting of backtest caveats. The methodology is fully documented — read every assumption before you rely on a single output.
Contact
Questions, bug reports, or feedback — support@tesseraalpha.com.